A Case of Guillain-Barré Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrosis Overlap After Pembrolizumab Treatment

• Main Authors: Tomoyo Oguri MD, PhD (Author), Shinji Sasada MD, PhD (Author), Satoko Shimizu MD (Author), Risa Shigematsu MD (Author), Yumi Tsuchiya MD (Author), Kota Ishioka MD (Author), Saeko Takahashi MD, PhD (Author), Koichi Oki MD, PhD (Author), Yoshifumi Kimura MD, PhD (Author), Reishi Seki MD (Author), Shigemichi Hirose MD, PhD (Author), Morio Nakamura MD, PhD (Author)
• Formato: Livro
• Publicado em: SAGE Publishing, 2021-08-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

A 76-year-old man was admitted to our hospital with Guillain-Barré syndrome (GBS), presenting with facial palsy, dysarthria, and dysphagia as Grade 3 immune-related adverse events (irAEs) due to pembrolizumab administration for Stage IV lung adenocarcinoma. Although prednisolone (1 mg/kg) was start...